Now authorized as a single booster dose:
Pfizer-BioNTech
COVID-19 Vaccine,
Bivalent
The vaccine may not protect everyone.
For children 5 through 11 years of age
as a primary series:
Pfizer-BioNTech
COVID-19 Vaccine
Now authorized as a single booster dose:
The vaccine may not protect everyone.
Emergency uses of
Emergency uses of the vaccines have not been approved or licensed by FDA but have been authorized by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (
Emergency uses of the vaccines have not been approved or licensed by FDA but have been authorized by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (
Dosing schedule for ages 5 to 11 years
Dosing schedule for
ages 5 to 11 years
Please see Dosing Schedule Below for People with Certain
Immunocompromising Conditions Please see Dosing Schedule Below
for People with Certain
Immunocompromising Conditions
Pfizer-BioNTech COVID-19 Vaccine
1st Dose
Dose
21 DAYS AFTER 1st DOSE
Pfizer-BioNTech COVID-19 Vaccine
2nd Dose
Dose
AT LEAST 2 MONTHS
Pfizer-BioNTech COVID-19 Vaccine,
Bivalent
Booster
21 days
At least
2 months
Pfizer-BioNTech COVID-19 Vaccine
1st Dose
FDA AUthorized
21 Days after 1st Dose
Pfizer-BioNTech COVID-19 Vaccine
2nd Dose
FDA AUthorized
At least 2 months
Pfizer-BioNTech COVID-19 Vaccine, Bivalent
Booster
FDA AUthorized
How is FDA-authorized
The vaccine is administered as a primary series of 2 doses that are given
3 weeks apart.
The vaccine is administered as a primary series of 2 doses that are given 3 weeks apart.
How is FDA-authorized
The bivalent booster can be given as a single booster dose to individuals 5 through 11 years of age at least 2 months after completion of primary vaccination with any authorized or approved monovalent
Learn more
For people with certain immunocompromising
conditions
Pfizer-BioNTech COVID-19 Vaccine
1st Dose
Dose
21 DAYS AFTER 1st DOSE
Pfizer-BioNTech COVID-19 Vaccine
2nd Dose
Dose
28 DAYS AFTER 2nd DOSE
Pfizer-BioNTech COVID-19 Vaccine
3rd Dose
Dose
For individuals with certain kinds of immunocompromise, a third primary series dose may be administered at least 28 days after the second dose.
AT LEAST 2 MONTHS AFTER 3rd DOSE
Pfizer-BioNTech COVID-19 Vaccine,
Bivalent
Booster
21 days
28 days
At least
2 months
Pfizer-BioNTech COVID-19 Vaccine
1st Dose
FDA AUthorized
21 Days after 1st Dose
Pfizer-BioNTech COVID-19 Vaccine
2nd Dose
FDA AUthorized
28 Days after 2nd Dose
Pfizer-BioNTech COVID-19 Vaccine
3rd Dose
FDA AUthorized
For individuals with certain kinds of immunocompromise, a third primary series dose may be administered at least 28 days after the second dose.
At least 2 months after 3rd Dose
Pfizer-BioNTech COVID-19 Vaccine, Bivalent
Booster
FDA AUthorized
How is FDA-authorized
The vaccine is administered as a primary series of 2 doses that are given 3 weeks apart. A third primary series dose may be administered at least 28 days after the second dose.
The vaccine is administered as a primary series of 2 doses that are given 3 weeks apart. A third primary series dose may be administered at least 28 days after the second dose.
How is FDA-authorized
The bivalent booster can be given as a single booster dose to individuals 5 through 11 years of age at least 2 months after completion of primary vaccination with any authorized or approved monovalent
Learn more
Find a vaccine
appointment
near you.
Take the next step toward helping to protect against
Your questions
about the vaccine
—- Answered.
If you’re considering the vaccine for your child, the information below can help you get started.
Recently Added
Additional Questions
There is a remote chance that the vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of the vaccine. For this reason, your child’s vaccination provider may ask your child to stay at the place where he or she received the vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include:
- difficulty breathing
- swelling of the face and throat
- a fast heartbeat
- a bad rash all over your child’s body
- dizziness and weakness
Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received the vaccine. In most of these people, symptoms began within a few days following receipt of the second dose of vaccine. The chance of having this occur is very low. You should seek medical attention right away if your child has any of the following symptoms after receiving the vaccine:
- chest pain
- shortness of breath
- feelings of having a fast-beating, fluttering, or pounding heart
Side effects that have been reported with the vaccine include:
- Severe allergic reactions
- Non-severe allergic reactions, such as rash, itching, hives, or
swelling of the face - Myocarditis (inflammation of the heart muscle)
- Pericarditis (inflammation of the lining outside the heart)
- Injection site pain
- Tiredness
- Headache
- Muscle pain
- Chills
- Joint pain
- Fever
- Injection site swelling
- Injection site redness
- Nausea
- Feeling unwell
- Swollen lymph nodes (lymphadenopathy)
- Decreased appetite
- Diarrhea
- Vomiting
- Arm pain
- Fainting in association with injection of the vaccine
These may not be all the possible side effects of the vaccine. Serious and unexpected side effects may occur. The possible side effects of the vaccine are still being studied in clinical trials.
Your child should not get the vaccine if they:
- had a severe allergic reaction after a previous dose of this vaccine
- had a severe allergic reaction to any ingredient of this vaccine
No. The vaccine does not contain the virus that causes
If your child experiences a severe allergic reaction or other severe symptom,
Call the vaccination provider or your healthcare provider if your child has any side effects that bother you or do not go away.
Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is
In addition, you can report side effects to Pfizer Inc. at the contact information provided below.
Website: www.pfizersafety
reporting.com
Fax number:
Telephone number:
Tell the vaccination provider about all of your child’s medical conditions, including if they:
- have any allergies
- have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)
- have a fever
- have a bleeding disorder or are on a blood thinner
- are immunocompromised or are on a medicine that affects their immune system
- are pregnant or plan to become pregnant
- are breastfeeding
- have received another
COVID-19 vaccine - have ever fainted in association with an injection
Individuals 5 years of age and older with immuno-compromising conditions may receive an additional primary series dose of vaccine 28 days after their second primary series dose. The third dose may still not provide full immunity to
